A new study published in the New England Journal of Medicine found that the 13-valent polysaccharide conjugate vaccine (Pfizer’s Prevnar 13/PCV13) was effective in protecting seniors from the strains of pneumococcus (a bacterium that causes infections Continue reading
↧
